Xspray Pharma AB (publ) (STO:XSPRAY)
Sweden flag Sweden · Delayed Price · Currency is SEK
13.72
+0.02 (0.15%)
Aug 13, 2026, 5:29 PM CET

Xspray Pharma AB Cash Flow Statement

Millions SEK. Fiscal year is Jan - Dec.
Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Jun '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Net Income
-138.73-156.91-287.04-181.73-133.07-97.95
Depreciation & Amortization
5.25.588.559.199.538.87
Other Adjustments
-20.42-11.4151.540.8516.9433.1
Change in Receivables
-7.9-0.41.34-4.11-2.94-5.71
Changes in Inventories
15.56-1.96-6.03-35.23--
Changes in Accounts Payable
-4.05-28.079.287.76-0.6310.09
Operating Cash Flow
-150.35-193.16-222.37-203.28-110.18-51.61
Operating Cash Flow Growth
------
Capital Expenditures
---4.38-2.69-24.47-1.31
Purchases of Intangible Assets
-19.73-29.19-37.76-49.86-103.82-94.65
Other Investing Activities
----13.33-7.06-9.85
Investing Cash Flow
-19.73-29.19-42.14-65.88-135.35-105.82
Long-Term Debt Issued
1201209645--
Long-Term Debt Repaid
-105.28-105.14-4.89-1.65-2.13-2.15
Net Long-Term Debt Issued (Repaid)
14.7314.8691.1143.35-2.13-2.15
Issuance of Common Stock
275.4161.13235.4297.9210099.88
Net Common Stock Issued (Repurchased)
275.4161.13235.4297.9210099.88
Other Financing Activities
-14.02-7.7-20.4-25.68-4.065.99
Financing Cash Flow
276.11168.29306.11315.5993.81103.71
Foreign Exchange Rate Adjustments
0.06-0.440.33-0.31--
Net Cash Flow
106.04-54.0641.646.44-151.72-53.72
Free Cash Flow
-150.35-193.16-226.75-205.97-134.65-52.92
Free Cash Flow Growth
------
FCF Margin
-1233.76%-3003.16%-10818.10%-648.37%-6176.38%-8067.07%
Free Cash Flow Per Share
-3.60-5.02-6.84-7.74-6.39-2.75
Levered Free Cash Flow
-128-181.04-187-157.29-149.36-81.21
Unlevered Free Cash Flow
-122.09-181.45-279.77-202.72-148.64-80.31